Healthline
September 25, 2025
Share on PinterestJayson Tatum teamed up with the Journavx to share how the non-opioid pain medication helped him during his recovery.Getty Images NBA star Jayson Tatum […]
September 24, 2025
Share on PinterestA common dietary supplement could be effective against non-melanoma skin cancer. Getty Images A new study found that nicotinamide (vitamin B3) use was linked […]
September 23, 2025
Share on PinterestA new CDC panel voted to make changes to childhood vaccination schedules and further narrow recommendations for COVID-19 shots. Shutterstock The CDC’s vaccine panel, […]
September 23, 2025
Share on PinterestThe FDA will advise physicians about the potential risks of Tylenol during pregnancy. Getty Images The Trump administration said the FDA will begin notifying […]
Medscape
July 1, 2025
TOPLINE: The prevalence of alcohol use and binge drinking declined among adolescents, but those with a recent history of suicidal thoughts and behaviors (STB) showed more […]
July 1, 2025
TOPLINE: Bacille Calmette-Guérin (BCG) revaccination showed no efficacy in preventing sustained Mycobacterium tuberculosis infection compared with placebo in adolescents, with similar rates of QuantiFERON-TB (QFT) test conversion […]
July 1, 2025
A prospective cohort study led by Yang Shao, PhD, president and CEO of Geneseeq Technology Inc. and professor at Nanjing Medical University, Nanjing, published in Nature […]
June 30, 2025
Continuing problems with the supply of medicines have become a “distressing new normal” for community pharmacies and patients, according to a report by Community Pharmacy England […]
FDA
December 8, 2025
As outlined in the GDUFA III Commitment Letter, these performance metrics must be reported each fiscal year. Original and PAS Review GDUFA FY Performance Review Time […]
December 5, 2025
Reports Mandated by FDORA The Food and Drug Omnibus Reform Act of 2022 (FDORA) requires FDA to develop several different kinds of informational documents, including public […]
December 4, 2025
On December 4, 2025, the Food and Drug Administration approved lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company) for adults with relapsed or refractory […]
December 4, 2025
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this […]
